MedPath

â??A Study to Assess the Effectiveness of Transitional Nursing Care on Process of Recovery, Prevention of Relapse and Readmission among Individuals with Severe Mental Illnesses: A Prospective Study in a Selected Institution of National Importance, Rajasthan, India.â??

Not Applicable
Conditions
Health Condition 1: F31- Bipolar disorderHealth Condition 2: F33- Major depressive disorder, recurrentHealth Condition 3: F20- Schizophrenia
Registration Number
CTRI/2020/12/029998
Lead Sponsor
ALL INDIA INSTITUTE OF MEDICAL SCIENCES JODHPUR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Individuals with Schizophrenia spectrum Disorders/Recurrent Depressive Disorder/Bipolar Affective Disorder diagnosed by the treating psychiatrist based on the ICD criteria.

17

• To be aged between 18 years to 65 years.

• The patient has at least one year duration of illness.

• The individual has been hospitalized for mental illness in Institution of National Importance.

• Able to comprehend Hindi or English language.

• Patient has been residing at home with family members or caregivers within the 15 kilometer radius from Jodhpur, Rajasthan.

Exclusion Criteria

Exclusion Criteria:

• Chronic mentally ill patients with co-morbid medical disorders (Ex: Cancer, HIV/AIDS, Neurological conditions, Renal failure etc,)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Process of recovery Work and Social Adjustment Scale (WSAS)â?¤10 <br/ ><br>2. Relapse A patient is considered to be in relapse if he or she has unchanged BPRS/YMRS/BDI scores from that at admission or an increase of scores from that at admission in to the follow up at first, third and sixth month after administration of TNC. <br/ ><br>3. Readmission In the present study, more than one admission during data collection period is considered as readmission.Timepoint: Post-intervention continuous assessment on I, III & VI months.
Secondary Outcome Measures
NameTimeMethod
Symptom Severity <br/ ><br>Functional Ability <br/ ><br>Medication AdherenceTimepoint: Post-intervention continuous assessment on I, III & VI months.
© Copyright 2025. All Rights Reserved by MedPath